Hall Laurie J Trustee Novartis Ag Transaction History

Hall Laurie J Trustee

$316 Million
Q3 2024

A detailed history of Hall Laurie J Trustee transactions in Novartis Ag stock. As of the latest transaction made, Hall Laurie J Trustee holds 27,552 shares of NVS stock, worth $2.86 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

27,552

Previous 27,592 0.14%

Holding current value

$2.86 Million

Previous $2.94 Million 7.9%

% of portfolio

1.0%

Previous 1.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$106.13 - $120.89 $4,245 - $4,835	-40 Reduced 0.14%	27,552 $3.17 Million
Q2 2024 Jul 22, 2024	SELL	$92.57 - $107.37 $6,017 - $6,979	-65 Reduced 0.24%	27,592 $2.94 Million
Q1 2024 Apr 23, 2024	SELL	$95.27 - $108.47 $13,337 - $15,185	-140 Reduced 0.5%	27,657 $2.68 Million
Q4 2023 Jan 11, 2024	BUY	$92.27 - $101.54 $2,306 - $2,538	25 Added 0.09%	27,797 $2.81 Million
Q3 2023 Oct 12, 2023	BUY	$94.73 - $105.13 $6,157 - $6,833	65 Added 0.23%	27,772 $2.83 Million
Q2 2023 Jul 14, 2023	BUY	$92.52 - $104.91 $462 - $524	5 Added 0.02%	27,707 $2.8 Million
Q1 2023 Apr 07, 2023	BUY	$80.03 - $92.81 $142,053 - $164,737	1,775 Added 6.85%	27,702 $2.55 Million
Q4 2022 Jan 11, 2023	BUY	$75.55 - $92.52 $2,266 - $2,775	30 Added 0.12%	25,927 $2.35 Million
Q3 2022 Oct 11, 2022	BUY	$74.61 - $87.26 $3,730 - $4,363	50 Added 0.19%	25,897 $1.97 Million
Q1 2022 Apr 06, 2022	BUY	$80.11 - $90.62 $10,814 - $12,233	135 Added 0.53%	25,847 $2.27 Million
Q4 2021 Jan 05, 2022	SELL	$79.7 - $88.13 $10,679 - $11,809	-134 Reduced 0.52%	25,712 $2.25 Million
Q2 2021 Jul 07, 2021	SELL	$85.24 - $94.15 $8,524 - $9,415	-100 Reduced 0.39%	25,846 $2.36 Million
Q1 2021 Apr 15, 2021	SELL	$83.5 - $98.47 $10,855 - $12,801	-130 Reduced 0.5%	25,946 $2.22 Million
Q4 2020 Jan 25, 2021	BUY	$78.07 - $94.43 $153,485 - $185,649	1,966 Added 8.15%	26,076 $2.46 Million
Q3 2020 Oct 09, 2020	BUY	$82.14 - $91.0 $19,713 - $21,840	240 Added 1.01%	24,110 $2.1 Million
Q4 2019 Feb 12, 2020	BUY	$84.35 - $95.37 $181,352 - $205,045	2,150 Added 9.9%	23,870 $2.26 Million
Q3 2019 Oct 25, 2019	SELL	$85.54 - $94.26 $6,843 - $7,540	-80 Reduced 0.37%	21,720 $1.89 Million
Q2 2019 Aug 01, 2019	SELL	$75.4 - $92.8 $11,310 - $13,920	-150 Reduced 0.68%	21,800 $1.99 Million
Q1 2019 May 02, 2019	SELL	$75.32 - $86.15 $101,983 - $116,647	-1,354 Reduced 5.81%	21,950 $2.11 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $67,840 - $75,540	921 Added 4.11%	23,304 $2.07 Million
Q3 2018 Oct 30, 2018	BUY	$66.94 - $77.43 $148,941 - $172,281	2,225 Added 11.04%	22,383 $1.93 Million
Q2 2018 Aug 01, 2018	BUY	$64.91 - $73.36 $37,323 - $42,182	575 Added 2.94%	20,158 $1.52 Million
Q1 2018 May 10, 2018	BUY	$70.39 - $84.15 $61,591 - $73,631	875 Added 4.68%	19,583 $1.58 Million
Q4 2017 Jan 30, 2018	BUY	$72.33 - $77.64 $75,584 - $81,133	1,045 Added 5.92%	18,708 $1.57 Million
Q3 2017 Oct 02, 2017	BUY	$74.14 - $77.27 $70,433 - $73,406	950 Added 5.68%	17,663 $0
Q2 2017 Aug 22, 2017	BUY	N/A	16,713	16,713 $0

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

News

Stay updated on Hall Laurie J Trustee with notifications on news.

Account

Hall Laurie J Trustee Novartis Ag Transaction History